GL1X · GenesisL1 explorer

Research workbench

Structural basis for the interaction of lactivicins with serine beta-lactamases

Analyse Structural basis for the interaction of lactivicins with serine beta-lactamases in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2X71
Type
protein
Length
510 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P94458
Ligands
L4C, SO4
Pockets
6 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-lactamase (EC 3.5.2.6)protein25542% helix, 18% strandP94458

Ligands and binding sites

  • L4C · (2E)-2-{[(2S)-2-(acetylamino)-2-carboxyethoxy]imino}pentanedioic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · chains B
  • EOH · Ethanol · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11470.590.8436empty
21600.540.8034empty
3660.420.8116empty
4550.410.8116empty
5590.320.7716L4C

Interfaces

1 interface between chains.

  • A–B · 678 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 2X71 · Structural basis for the interaction of lactivicins with serine beta- lactamases · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.